DaVita Posts 3Q Adjusted EPS of $3.82
DVA sits 91% above its 52-week low of $101 on elevated volume (2.4× avg).
Summary
DaVita reported third-quarter adjusted EPS of $3.40. The headline carries no revenue, net income, or guidance figures, so the comparison to the $14.10-$15.20 full-year adjusted EPS range issued with Q2 results in August isn't possible yet. Q2 showed momentum — net income of $265 million, up 33% year-over-year — and the company has been buying back stock, so the bar was elevated. The full release and any updated 2026 guidance will determine whether this quarter extends that trend or marks a slowdown.
At the time of this announcement, DVA was trading at $193.31 on NYSE in the Life Sciences sector, with a market capitalization of approximately $12.3B. The 52-week trading range was $101.00 to $247.49. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.